Coronary Artery Disease Journal

SEPTEMBER 24, 2024

Introduction Despite advancements in coronary artery disease (CAD) management, major adverse cardiovascular events persist. Primary outcomes included myocardial infarction, stroke, major bleeding events, and all-cause mortality. 0.95; P = 0.002), myocardial infarction (HR, 0.81; 95% CI, 0.70–0.94;

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Strokes Stroke 40

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk.

Coronary Artery Bypass Graft 59

Coronary Artery Bypass Graft Coronary Artery Disease Heart Failure Myocardial Infarction 59

Med Page Today

APRIL 10, 2024

(MedPage Today) -- ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in better outcomes compared.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Outcomes STEMI 64

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. The odds of adverse outcomes such as mortality (aOR 3.90, 95% CI: 3.48–4.36), Mortality (43.2%

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform. Accessed May 2024. Leon, Shubin Qiao, Gregg W.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

Cardiology Update

MARCH 25, 2024

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes.

Diabetes 122

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease 122

American College of Cardiology

JULY 10, 2024

What is the outcome of contemporary revascularization strategies in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease (CAD)?

Coronary Artery Disease 61

Coronary Artery Disease Myocardial Infarction Outcomes Article 61

Open Heart

AUGUST 21, 2023

Background Insights on the differences in clinical outcomes, quality of life (QoL) and health resource utilisation (HRU) with different levels of care available to post-acute myocardial infarction (AMI) populations in rural and urban settings are limited. The adjusted incidence rate ratio was 0.92 (95% CI, 0.74

Myocardial Infarction 52

Myocardial Infarction Angina Outcomes Coronary Artery Disease 52

European Journal of Heart Failure

OCTOBER 5, 2023

In this study, two independent cohorts were used to investigate for cardiovascular magnetic resonance (CMR) and genetic features of dilated cardiomyopathy (DCM) in individuals with coronary artery disease (CAD). NI-LGE was not independently associated with adverse clinical outcomes. vs. 6.7%, odds ratio 1.5,

Coronary Artery Disease 40

Coronary Artery Disease Cardiomyopathy Outcomes Myocardial Infarction 40

Coronary Artery Disease Journal

JUNE 10, 2024

Background Despite improvements in outcomes of ST elevation myocardial infarction (STEMI), ventricular septal rupture (VSR) remains a known complication, carrying high mortality. Methods The National Inpatient Sample database (2009–2020) was used to study trends in admissions and outcomes of post-STEMI VSR over time.

Myocardial Infarction 40

Myocardial Infarction STEMI Outcomes Inpatient 40

Coronary Artery Disease Journal

JANUARY 11, 2024

Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. Previous studies showed considerable risks of outcomes in this group. In this study, we aimed to investigate the long-term outcomes in very young patients with MINOCA.

Myocardial Infarction 40

Myocardial Infarction Outcomes Atrial Fibrillation Risk Factors 40

Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other cardiovascular risk factors, the.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction Risk Factors Outcomes 52

Nature Reviews - Cardiology

MAY 6, 2024

Nature Reviews Cardiology, Published online: 07 May 2024; doi:10.1038/s41569-024-01014-0 In 1993, Lincoff and Topol claimed that the thrombolytic treatment of ST-segment elevation myocardial infarction was suboptimal in many patients and gave an ‘illusion of reperfusion’.

Coronary Artery Disease 69

Coronary Artery Disease Myocardial Infarction Article Outcomes 69

Open Heart

JUNE 5, 2024

We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. Patients with coronary artery disease were excluded. The primary outcome was 30-day mortality. vs 3.6%, p=0.019) and arrhythmia (11.2%

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

Open Heart

OCTOBER 27, 2023

Percutaneous coronary intervention (PCI) is widely adopted to treat chronic coronary artery disease. In this review, we discuss the current evidence in favour and against PCI in stable coronary syndromes and highlight the pitfalls of the available studies.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Outcomes 52

Open Heart

JUNE 21, 2022

Background Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial.

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Artery Disease Outcomes 52

All About Cardiovascular System and Disorders

MAY 26, 2024

It is now well known that even if a coronary artery is opened well after a myocardial infarction, with good flow in the epicardial coronary arteries, there could be impaired myocardial perfusion. Transit time is measured by saline bolus injection using a thermodilution technique. Banning, William F.

STEMI 52

STEMI Outcomes Coronary Artery Disease Myocardial Infarction 52

Coronary Artery Disease Journal

NOVEMBER 20, 2023

Background: Gender-specific outcomes after percutaneous coronary interventions were studied by a number of research groups with different endpoints and cohorts of different ethnic extractions. Results: Overall, in the unmatched cohorts, accumulated target-lesion revascularization rates did not differ between both genders (2.7%

Stent 52

Stent Stents Outcomes Coronary Artery Disease 52

Circulation

NOVEMBER 11, 2024

Cigarette smoking is a significant risk factor for coronary artery disease (CAD). However, evidence regarding on the long-term clinical effects of smoking in the Asian population with chronic total coronary occlusion (CTO) is insufficient. years, interquartile range 4.06-5.0

Outcomes 40

Outcomes Coronary Artery Disease Myocardial Infarction Risk Factors 40

CardiacWire

MAY 10, 2024

A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheral artery disease surgeries has a massive impact on coronary artery disease detection, treatments, and long-term outcomes.

Coronary Artery Disease 59

Coronary Artery Disease Peripheral Arterial Disease Ischemia Myocardial Infarction 59

DAIC

OCTOBER 30, 2024

Data confirm the use of FFR CT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease. tim.hodson Wed, 10/30/2024 - 11:23 Oct. 27, 2024 — HeartFlow, Inc. IR versus 7.8% cardiologist at University Hospital of Southern Denmark.

Plaque 52

Plaque Outcomes Coronary Artery Disease Chest Pain 52

Coronary Artery Disease Journal

MAY 29, 2024

Background Despite advances in percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction (STEMI), in-hospital mortality remains a concern, highlighting the need for the identification of additional risk factors such as serum iron levels.

Myocardial Infarction 40

Myocardial Infarction Hospital STEMI Risk Factors 40

Dr. Paddy Barrett

APRIL 5, 2024

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

Heart Disease 103

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 103

Circulation

NOVEMBER 11, 2024

The outcome measure was peri-procedural complications defined as a composite of perioperative death, major bleeding, contrast nephropathy, myocardial infarction, ischemic stroke, and major amputation. A history of coronary artery disease was noted in 40.7% and dialysis at 29.9%, respectively.

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Disease Ischemia Strokes 40

Coronary Artery Disease Journal

NOVEMBER 26, 2023

Aim Acute injury and subsequent remodelling responses to ST-segment elevation myocardial infarction (STEMI) are major determinants of clinical outcome. Current imaging and plasma biomarkers provide delayed readouts of myocardial injury and recovery.

Myocardial Infarction 40

Myocardial Infarction STEMI Biomarkers Outcomes 40

Circulation: Cardiovascular Interventions

NOVEMBER 28, 2023

The primary end point was target vessel failure defined as a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization.Results:At a median follow-up of 2.1 years (interquartile range 1.1 versus 25.1%; hazard ratio, 0.31 [95% CI, 0.13–0.76];P=0.010). 0.76];P=0.010).

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Disease Cardiovascular Interventions Outcomes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

Introduction The presence of non-coronary atherosclerosis (NCA) in patients with coronary artery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronary artery bypass grafting (CABG). vs. 9%, p  < 0.001).

Coronary Artery Bypass Graft 64

Coronary Artery Bypass Graft Atherosclerosis Peripheral Arterial Disease Coronary Artery Disease 64

Frontiers in Cardiovascular Medicine

FEBRUARY 12, 2024

Background There is mounting data supporting the use of drug-coated balloons (DCB) not only for treatment of in-stent restenosis (ISR), but also in native coronary artery disease. Angiograms and outcomes were independently adjudicated. So far, paclitaxel-coated balloons represented the mainstay DCBs. IQR 12; 14.2)

Coronary Artery Disease 59

Coronary Artery Disease Myocardial Infarction Stent Stents 59

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Patients are eligible for recruitment if they have severe left ventricular systolic dysfunction, extensive coronary artery disease, and are due to undergo complex percutaneous coronary intervention (to the left main stem with calcium modification or to a chronic total occlusion with a retrograde approach).

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Coronary Artery Disease Quality of Life 40

Cardiology Update

FEBRUARY 14, 2024

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Thrombosis Research 52

All About Cardiovascular System and Disorders

APRIL 21, 2024

FAME study showed that at one year follow up, rate of major adverse coronary events was reduced by approximately 30% by routinely measuring FFR. Routine FFR measurement probably lead to more judicious use of stents and improved outcomes. They had lower rates of mortality or myocardial infarction. Cut off FFR was 0.8

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Stent Stents 52

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

were found to have obstructive coronary artery disease (CAD). of cases, CAG findings resulted in myocardial revascularization. Posttransplant MACE has a negative effect on grafts and patient outcomes. Asymptomatic obstructive CAD was observed in 70.2% Conclusion Asymptomatic CVD is largely prevalent in KTR.

Transplant 64

Transplant Coronary Artery Disease Myocardial Infarction Cardiovascular Disease 64

The British Journal of Cardiology

APRIL 16, 2024

We present the cumulative percutaneous coronary intervention (PCI) data of all comers (stable angina and acute coronary syndromes [ACS]) who presented to Hadi Clinic between January 2018 and December 2020. Prospectively collected data of all comers for PCI (urgent and elective) were retrospectively analysed.

Outcomes 52

Outcomes Cardiogenic Shock Angina STEMI 52

Stroke Journal

DECEMBER 8, 2023

The primary outcome was ischemic stroke; the secondary outcome was combined cardiovascular events (ischemic stroke, myocardial infarction, and cardiovascular death). The plaque-related risk of outcomes was also analyzed according to the presence of statin treatment. During a mean follow-up of 11.3±3.6

Plaque 40

Plaque Aortic Strokes Stroke 40

Circulation

MARCH 11, 2024

BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Circulation, Ahead of Print. PintHR=0.87) diabetes.

Coronary Artery Bypass Graft 81

Coronary Artery Bypass Graft Diabetes Coronary Artery Disease Stent 81

Open Heart

OCTOBER 26, 2022

Objectives Compare the safety and efficacy of BVS versus DES in patients receiving percutaneous coronary intervention for coronary artery disease across a complete range of randomised controlled trial (RCT) follow-up intervals. All other outcomes were statistically equivalent.

Stent 52

Stent Stents Coronary Artery Disease Myocardial Infarction 52

Cardiology Update

APRIL 9, 2024

EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). Here is our curated list of the top sessions.

Myocardial Infarction 52

Myocardial Infarction Angina Aortic valve Coronary Artery Disease 52